Splenic lymphoma in a patient treated with interleukin-2 and dacarbazine for metastatic melanoma.
Shiloni
E
E
Department of Surgery, Hadassah University Hospital, Jerusalem, Israel.
Maclennan
K A
KA
Okon
E
E
Polliack
A
A
D000328:Adult; D003606:Dacarbazine / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects* / Q000627:therapeutic use; D008207:Lymphatic Metastasis; D008223:Lymphoma / Q000139:chemically induced* / Q000175:diagnosis; D008297:Male; D008545:Melanoma / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D012878:Skin Neoplasms / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D013160:Splenic Neoplasms / Q000139:chemically induced* / Q000175:diagnosis
D007376:Interleukin-2; D003606:Dacarbazine